(20371917), S. K. (2025). Supplementary Figure 5: Pathway analysis after treatment with KC and KCM serum in precursor cells.
Čikaški stil citiranja (17. izdanje)(20371917), Sushil Kumar. Supplementary Figure 5: Pathway Analysis After Treatment with KC and KCM Serum in Precursor Cells. 2025.
MLA način citiranja (9. izdanje)(20371917), Sushil Kumar. Supplementary Figure 5: Pathway Analysis After Treatment with KC and KCM Serum in Precursor Cells. 2025.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.